GLP-1 Weight Loss Drugs Trigger a Life-Threatening Brain Condition by Depleting Vitamin B1

• Researchers found 15 documented cases of Wernicke encephalopathy linked to GLP-1 drug use — Of them, 13 were reported through the FDA database, one from the medical literature, and one from the researchers’ own hospital experience. Most reports clustered in 2023 and 2024, which mirrors the explosive rise in GLP-1 prescriptions. Reports of Wernicke encephalopathy were more than twice as likely with GLP-1 drugs compared with other medications.

• Nearly every affected patient shared the same risk profile — Thirteen of the 15 individuals experienced severe gastrointestinal symptoms such as persistent vomiting, appetite loss, rapid weight loss, or malnutrition before neurological symptoms appeared. The study emphasizes that GLP-1 drugs slow gastric emptying and suppress appetite, which increases the likelihood of prolonged nutrient depletion.

• Certain drugs appeared far more often than others — Eight of the 15 cases involved semaglutide, marketed as Ozempic or Wegovy, and six involved tirzepatide, sold under the brand name Mounjaro.²

• Classic neurological symptoms were often incomplete, which delayed diagnosis — Only two patients showed the full textbook triad of confusion, eye movement problems, and gait instability. Eleven showed partial symptoms, and some showed none at first. This matters because clinicians often wait for obvious signs before testing or treating vitamin B1 deficiency.

Unlike fat-soluble vitamins that your body stores for months, vitamin B1 is water-soluble with minimal reserves — your body holds only about 30 milligrams at any time, enough for roughly two to three weeks. During rapid weight loss, metabolic demands actually increase while intake plummets, depleting stores at an accelerated rate.

Among the 11 patients with follow-up data, seven were left with permanent neurological damage despite treatment. That means more than half experienced lasting harm that did not resolve even after vitamin B1 replacement.

• The study highlights a glaring gap in current medical practice — Despite decades of awareness that rapid weight loss and vomiting trigger vitamin B1 deficiency in bariatric surgery patients, no formal guidelines require routine vitamin monitoring for people taking GLP-1 drugs for weight loss.

For those taking GLP-1 drugs, recognizing early warning signs such as ongoing nausea, dizziness, confusion, or trouble walking allows timely vitamin B1 testing and treatment, which may reverse symptoms when done early. But the study raises a deeper question: why does B1 depletion cause such catastrophic damage so quickly? A commentary by bioenergetic researcher Georgi Dinkov provides the missing mechanistic piece.³

• Lactic acid builds up rapidly when PDH function drops — Impaired PDH activity forces glucose to convert into lactate instead of entering normal energy pathways. Lactate buildup damages tissues directly, especially in your brain and heart, and creates an internal acidic environment that cells struggle to survive.

• The health consequences extend far beyond neurological symptoms alone. Dinkov links reduced PDH activity to a range of disorders, including depression, psychosis, diabetes, heart disease, and cancer, all tied to impaired glucose oxidation.

Once lactic acid accumulates to dangerous levels, outcomes deteriorate fast. Severe lactic acidosis carries a reported mortality rate of 30% to 40% even with hospital treatment, which places metabolic collapse among the most lethal downstream effects of B1 depletion.

• The risks don’t disappear when symptoms look mild — Dinkov notes that even partial suppression of vitamin B1 activity still disrupts PDH function. Lower drug doses that blunt appetite without extreme vomiting still create metabolic stress that compounds over time.

• Multiple established GLP-1 side effects intensify metabolic stress — Beyond appetite suppression, GLP-1 drugs associate with gastroparesis (delayed stomach emptying), vision loss, and other neurological complications, all of which reflect impaired energy production in tissues with high fuel demand.

Delayed stomach emptying prolongs nausea, early fullness, and nutrient depletion, while visual damage signals ongoing metabolic failure in your nervous system. For patients, persistent digestive or sensory symptoms are not harmless trade-offs; they show that the metabolic imbalance driving harm remains active and uncorrected.

1. Stop using GLP-1 drugs and remove the metabolic stressor — If you’re taking a GLP-1 drug, stopping it removes the constant pressure that suppresses appetite, slows digestion, and drains nutrients. Once that stress lifts, your body reallocates resources toward repair instead of survival. This single step protects your brain, stabilizes energy production, and prevents further nutrient depletion that drives neurological injury.

2. Use a GLP-1 strategy that works with your biology, not against it — A biology-informed approach can encourage broader conversations about metabolism. In my book, “Weight Loss Cure: Melt Fat Naturally with Your Own GLP-1,” I explore general lifestyle, nutrition, and digestive health concepts and their relationship to metabolic function.

The book is educational in nature and does not claim to diagnose, treat, cure, or prevent any disease. Individuals should consult a qualified healthcare professional regarding medical or treatment decisions.

3. Repair your gut so Akkermansia regulates appetite naturally — Akkermansia muciniphila is a key gut bacterium that helps trigger your body’s own GLP-1 release through proteins it naturally secretes. When your gut barrier is damaged by seed oils, inflammation, and metabolic stress, this system shuts down. Fixing gut integrity first restores steady appetite control without malnutrition or energy failure. If your gut is not stable, repair comes before adding fiber or supplements.

You might wonder what seed oils have to do with vitamin B1 and brain health. The connection is mitochondrial function. Seed oils high in linoleic acid (LA) create oxidative stress in your mitochondria — the same cellular power plants that B1 helps run. Eliminating one stressor while addressing another creates compounding benefits for energy production.

4. Create an environment where beneficial gut bacteria thrive — Eliminating seed oils high in LA reduces mitochondrial stress and gut inflammation, which allows Akkermansia to take hold. Aim to keep daily LA intake under 5 grams, ideally closer to 2 grams. When my Pax health coaching platform launches, the Seed Oil Sleuth feature will help you track this down to the tenth of a gram.

Replace seed oils with grass fed butter, ghee, or tallow. After your digestion stabilizes, introduce polyphenol-rich foods such as berries and gentle inulin sources like leeks or garlic. Think of gut repair as building a house: you wouldn’t install cabinets before the foundation is set. Each step creates the conditions for the next to succeed.

5. Restore protein and carbohydrates to rebuild energy and tissue — If your appetite stayed low for weeks or months, your body has been running on a deficit. Increase protein slowly until intake reaches about 0.8 grams per pound of ideal body weight (or about 1.76 grams per kilogram), with roughly one-third from collagen-rich sources such as bone broth, natural gelatin, oxtail, or connective-tissue-rich beef.

Pair this with gradual carbohydrate reintroduction, starting with easy-to-digest options like fruit or white rice before moving to more complex carbs. Adequate glucose signals safety to your metabolism. Without it, your body stays in crisis mode — hoarding resources rather than investing them in repair. This is why low-carb diets often backfire during recovery.